Ziagen Alternatives Compared
| Ziagen (abacavir) | Cabenuva (cabotegravir / rilpivirine) | Truvada (emtricitabine / tenofovir disoproxil) |
|
|---|
| Ziagen (abacavir) | Cabenuva (cabotegravir / rilpivirine) | Truvada (emtricitabine / tenofovir disoproxil) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Occupational Exposure, HIV Infection, Nonoccupational Exposure. Ziagen may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for HIV Infection. Cabenuva may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pre-Exposure Prophylaxis, Occupational Exposure, HIV Infection, Nonoccupational Exposure. Truvada may also be used for purposes not listed in this medication guide. |
||||||||||||||||
| More about Ziagen (abacavir) | More about Cabenuva (cabotegravir / rilpivirine) | More about Truvada (emtricitabine / tenofovir disoproxil) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Cabenuva has an average rating of 8.0 out of 10 from a total of 22 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 5% reported a negative effect. |
Truvada has an average rating of 6.4 out of 10 from a total of 39 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Cabenuva prices |
View all Truvada prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
Other emtricitabine / tenofovir disoproxil brands include: AccessPak for HIV PEP Basic | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
2 hours |
50 hours (empirically) |
25.7 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 54 drugs are known to interact with Ziagen:
|
A total of 451 drugs are known to interact with Cabenuva:
|
A total of 241 drugs are known to interact with Truvada:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
December 17, 1998 |
January 21, 2021 |
August 02, 2004 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.